ANI PHARMACEUTICALS, INC Shareholders' Equity
ANI PHARMACEUTICALS, INC (ANIP) had Shareholders' Equity of $597.21 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity Attributable to Parent $597.21M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $562.30M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $540.72M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $505.82M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $597.21M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $562.30M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $540.72M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $505.82M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $436.76M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $418.62M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $403.68M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $405.95M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $455.76M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $451.96M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $432.75M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $429.86M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $409.62M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $314.63M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $313.69M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $311.82M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $312.11M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $321.24M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $333.89M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $191.40M 10-Q · filed 2021-11-01 | |
| 2021-06-30 | $191.92M 10-Q · filed 2022-08-08 | |
| 2021-03-31 | $203.71M 10-Q · filed 2022-08-08 | |
| 2020-12-31 | $195.70M 10-Q · filed 2022-08-08 | |
| 2020-09-30 | $195.10M 10-Q · filed 2021-11-01 | |
| 2020-06-30 | $191.34M 10-Q · filed 2021-11-01 | |
| 2020-03-31 | $201.17M 10-Q · filed 2021-08-06 | |
| 2019-12-31 | $212.79M 10-K · filed 2022-03-15 | |
| 2019-09-30 | $213.13M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $207.66M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $199.71M 10-Q · filed 2020-08-06 | |
| 2018-12-31 | $197.26M 10-K · filed 2022-03-15 | |
| 2018-09-30 | $192.47M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $185.11M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $179.64M 10-Q · filed 2019-08-07 | |
| 2017-12-31 | $174.76M 10-K · filed 2021-03-11 | |
| 2017-09-30 | $182.80M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $176.55M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $172.21M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $169.65M 10-K · filed 2020-02-27 | |
| 2016-09-30 | $168.83M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $163.78M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $160.18M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $160.08M 10-K · filed 2019-02-27 | |
| 2015-09-30 | $155.89M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $149.50M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $144.74M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $139.78M 10-K · filed 2018-02-27 | |
| 2014-09-30 | $99.49M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $91.59M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $92.09M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $40.96M 10-K · filed 2017-03-02 | |
| 2013-09-30 | $36.69M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $35.49M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $26.03M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | -$42.72M 10-K · filed 2016-02-23 | $28.18M 10-K · filed 2013-02-28 |
| 2012-09-30 | $32.29M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $30.92M 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $38.00M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | -$34.28M 10-K · filed 2014-02-28 | $37.82M 10-K · filed 2012-03-13 |
| 2011-09-30 | $44.15M 10-Q · filed 2011-11-09 | |
| 2010-12-31 | $19.15M 10-K · filed 2013-02-28 | |
| 2009-12-31 | $15.83M 10-K · filed 2013-02-28 | |
| 2008-12-31 | $13.83M 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |